← Back to Search

Communities That HEAL Intervention for Opioid Use Disorder

N/A

Waitlist Available

Research Sponsored by RTI International

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up months 19-30

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new intervention aimed at reducing opioid overdose deaths by 40% in 67 communities that are highly affected by addiction.

Who is the study for?

The HEALing Communities Study is for communities in Kentucky, Ohio, Massachusetts, or New York that are heavily impacted by opioid overdoses. Eligible communities must have a high rate of opioid-related deaths and be willing to implement strategies like medication-assisted treatment (MOUD), overdose training, and naloxone distribution.

What is being tested?

This study tests the 'Communities That HEAL' intervention aimed at reducing opioid overdose deaths by 40%. Some communities will start the program right away while others will wait to begin. The effectiveness of this community-wide approach on preventing deaths from opioids is being compared.

What are the potential side effects?

Since this trial involves community interventions rather than medications, there aren't traditional side effects. However, potential challenges could include resistance to change within communities or difficulties in coordinating across different sectors like healthcare and justice.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ months 19-30

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~months 19-30

This trial's timeline: 3 weeks for screening, Varies for treatment, and months 19-30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of opioid overdose deaths

Secondary study objectives

Opioids

Buprenorphine

Naloxone

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wave 2 - Wait-list comparisonExperimental Treatment1 Intervention

Communities in Wave 2 will continue usual care during the first 30 months of the trial. At month 31, Wave 2 communities will begin receiving the CTH intervention.

Group II: Wave 1 - InterventionExperimental Treatment1 Intervention

Communities in Wave 1 will receive the CTH intervention during the first 30 months of the trial. The intervention will include 3 components: community engagement to assist key stakeholders in applying evidence-based practices to addressing their opioid crisis, a menu of evidence-based practices for communities to select and implement, and a communications campaign to build demand for evidence-based practices to address overdose and opioid use disorder.

Do I qualify?Apply below to find out